People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biological Dynamics Inc | — | Biotechnology | Series B | $44.8M | $476.3M | 2019 |
Martin Mark Wygod at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin Mark Wygod on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| Michael Russell | 1 | 6 |
| Paul Billings | 1 | 5 |
| Paul Maier | 1 | 4 |
| John L. Miller | 1 | 2 |
| Rajaram Krishnan | 1 | 1 |
| David Charlot | 1 | 1 |
| Irwin Mark Jacobs, Sc.D. | 1 | 1 |
| Rajaram Krishnan, Ph.D. | 1 | 1 |
| Richard Mark Slansky | 1 | 1 |
| Sanjay Mark Jha, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.